Please login to the form below

Not currently logged in

Sanofi licenses cardiovascular therapy in South Korea

Sanofi reception

Phase III drug comes from Swedish company NeuroVive

Boehringer bags FDA approval for Spiriva-based combo

Boehringer Ingelheim headquartersStiolto given the thumbs up as a once-daily maintenance therapy for COPD

Amgen’s immuno-oncology drug scores in skin cancer

Amgen flagFirm hoping its novel treatment will be on the market be the end of this year

Three cancer immunotherapies amongst new CHMP approvals

EU flagBMS’ Evotaz also amongst eight new medicine recommendations

Clinical research in children lagging, says report

Report found children are missing out on treatment advances that are helping adults

Amgen decision on brodalumab unsettles anti-IL-17 class

Amgen flagMove made following data found linking the drug to suicidal thoughts

AZ escapes censure over cancer tweet

AstraZeneca AZ headquarters London UKFirm did not breach UK’s Code of Practice over survival statistics post

Disappointment for pharma with new Cancer Drugs Fund list

Roche Avastin bevacizumab cancerBayer the only firm to win a reprieve from the CDF drug cull

EMA prepares to launch medical literature monitoring service

European Medicines Agency (EMA)Will screen documents for 400 active substance groups

Get Real! The Rise of Observational Data In Healthcare

Real world data is now becoming a serious research tool for pharma, but just what can it add to the golden standard that is the randomised clinical trial?

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Blue Latitude

We are experts in customer engagement. A strategic multichannel marketing and customer experience consultancy. Our focus is creating exceptional customer...

Latest intelligence

Webinar: The right e-detailing content for rich data
Data is the fuel for your digital communication – powering you to not only learn about your customers but communicate more effectively too....
How do you solve a problem like non-adherence? Part 1
Recent research from the World Health Organisation and the Mayo Clinic on the impact of (and influences on) a patient’s ability to adhere to their treatment regime has shown that...
How to design patient services with social media within the ABPI code guidelines
In this blog, Senior Consultant Craig Moore, from the Blue Latitude Strategy team, discusses the application of the ABPI Code, including incorporating social media into digital patient services....